8.9(top 1%)
Impact Factor
9.8(top 1%)
extended IF
213(top 1%)
H-Index
authors
15.2K
papers
527.3K
citations
citing journals
citing authors

Most Cited Articles of Journal of Nuclear Medicine

TitleYearCitations
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors20092.5K
Partial-volume effect in PET tumor imaging20071K
Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution1986940
A combined PET/CT scanner for clinical oncology2000929
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine2005861
Recommendations on the use of 18F-FDG PET in oncology2008814
Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy2015765
Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation1983745
Automatic quantification of ejection fraction from gated myocardial perfusion SPECT1995729
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT2007724
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography1992702
Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner2011665
Skeletal PET with 18F-fluoride: applying new technology to an old tracer2008656
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET1995655
Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis1983617
Standards for PET image acquisition and quantitative data analysis2009592
Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data2009580
Correction for partial volume effects in PET: principle and validation1998578
A tabulated summary of the FDG PET literature2001534
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT2006527
The applications of PET in clinical oncology1991524
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer2011522
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)2010513
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias2008503
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials2006499